missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CCDC19 (aa 135-217) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (89%), Rat (89%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-60439 (PA5-60439. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The function remains unknown.
Specifications
Specifications
| Accession Number | Q9UL16 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 25790 |
| Name | Human CCDC19 (aa 135-217) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1700028D05Rik; CCDC19; CFAP45; cilia and flagella associated protein 45; cilia- and flagella-associated protein 45; coiled-coil domain containing 19; Coiled-coil domain-containing protein 19; coiled-coil domain-containing protein 19, mitochondrial; nasopharyngeal epithelium specific protein 1; nasopharyngeal epithelium specific protein 1 (NESG1); nasopharyngeal epithelium-specific protein 1; NESG1; protein CFAP45, mitochondrial; Unknown (protein for MGC:134208) |
| Common Name | CCDC19 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction